Market Access, also known as Global Evidence, Value and Access, is the process used to ensure that all patients who are eligible to benefit from a specific treatment get access to it, at the appropriate price.
The process for healthcare companies in developing their market access strategy, requires both internal and external focus and investment, and is designed to meet the needs of the payer audience, Ministries of Health, and other key stakeholders. Core components include:
- Value Identification: How do we interpret value for the payer; is the product reasonable and necessary, in comparison to existing treatments?
- Value Creation: How do we define the value story through HEOR initiatives and data? How does the manufacturer incorporate HEOR metrics into the clinical trial study design?
- Value Communication: How do we communicate the value story to key stakeholders, i.e. development of a global HTA dossier.
The market access process is conducted as a global initiative that also addresses the needs of stakeholders at the local level. Global value dossiers (the key deliverable in market access – is developed in collaboration with target markets and across internal business functions) must be adapted to meet the needs of specific market access customers at both the national and local level, to address the unique aspects of each healthcare system.
YouthView: Understanding risk behaviours for meningitis among young people
While meningococcal meningitis is relatively uncommon, it is unpredictable, may progress very rapidly and can lead to death in as little as 24 hours of first symptoms.<sup>1,2</sup>
According to one study, the bacteria that can cause the disease are carried asymptomatically in the nasopharynx of up to almost one in four (24%) 19-year-olds; although for most it will not cause the disease.<sup>3</sup>
Oncology: The Disease, The Dynamics & The Complexities (2018)
Cancer is one term that encompasses many different diseases. There is no one cause of cancer, nor is there a single treatment protocol. Incidence and prevalence rates differ globally, treatment is managed by numerous physician specialties and our ever-evolving understanding of the disease makes it challenging to remain current…
[EVENT] SampleCon 2019
On February 11, join Ipsos at this year’s marquee Survey Sampling industry conference. Ipsos is pleased to be on the Board of Directors of SampleCon, North America’s industry association focused on shaping a thriving sample industry and helping to drive the sample/sampling agenda for the industry. Since its inception in 2013, SampleCon has grown rapidly, with both clients and suppliers now attending the annual conference.